These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20298550)

  • 21. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
    Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
    J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
    Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
    Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-surgical combined modality treatments for laryngeal organ preservation in advanced hypopharyngeal carcinoma].
    Zhang X; Wang J; Wu W; Ma L; Liu M; Zhao F; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):558-63. PubMed ID: 25257270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.
    Fury MG; Lee NY; Sherman E; Lisa D; Kelly K; Lipson B; Carlson D; Stambuk H; Haque S; Shen R; Kraus D; Shah J; Pfister DG
    Cancer; 2012 Oct; 118(20):5008-14. PubMed ID: 22415650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
    Clavel S; Nguyen DH; Fortin B; Després P; Khaouam N; Donath D; Soulières D; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):582-9. PubMed ID: 21277695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperfractionated radiotherapy and concomitant cisplatin for locally advanced laryngeal and hypopharyngeal carcinomas: final results of a single institutional program.
    de la Vega FA; García RV; Domínguez D; Iturre EV; López EM; Alonso SM; Romero P; Sola JM
    Am J Clin Oncol; 2003 Dec; 26(6):550-7. PubMed ID: 14663370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
    Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
    Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
    Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
    Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surviving hypopharynx-larynx carcinoma in the era of IMRT.
    Studer G; Peponi E; Kloeck S; Dossenbach T; Huber G; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1391-6. PubMed ID: 20056352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of concurrent chemoradiation in laryngeal preservation for supraglottic cancer.
    Yoon TM; Lee JK; Cho JS; Lim SC; Chung WK
    J Otolaryngol Head Neck Surg; 2010 Apr; 39(2):142-9. PubMed ID: 20211100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent chemoradiotherapy with helical tomotherapy for oropharyngeal cancer: a preliminary result.
    Shueng PW; Wu LJ; Chen SY; Hsiao CH; Tien HJ; Cheng PW; Kuo YS; Chen YJ; Chen CA; Hsieh PY; Hsieh CH
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):715-21. PubMed ID: 19879069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer.
    Nomura K; Takahara M; Katayama A; Kishibe K; Kunibe I; Katada A; Hayashi T; Harabuchi Y
    Laryngoscope; 2013 Apr; 123(4):916-22. PubMed ID: 23280966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
    Folkert MR; Shih KK; Abu-Rustum NR; Jewell E; Kollmeier MA; Makker V; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Feb; 128(2):288-93. PubMed ID: 23159818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant weekly cisplatin and radiotherapy for head and neck cancer.
    Homma A; Inamura N; Oridate N; Suzuki S; Hatakeyama H; Mizumachi T; Kano S; Sakashita T; Onimaru R; Yasuda K; Shirato H; Fukuda S
    Jpn J Clin Oncol; 2011 Aug; 41(8):980-6. PubMed ID: 21715362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.